Promiscuous genes and chromosomal rearrangements of hematopoietic malignancies.

被引:0
|
作者
Berger, R
机构
[1] Inst Mol Genet, CNRS, F-75010 Paris, France
[2] INSERM, U434, F-75010 Paris, France
来源
ANNALES DE GENETIQUE | 1999年 / 42卷 / 01期
关键词
hematopoietic malignancies; leukemia; chromosomes; translocation; fusion genes;
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The nonrandomness of chromosomal abnormalities of hematopoietic malignancies, which has been established twenty years ago, has evidenced a more or less close relationship between some structural chromosomal abnormalities and leukemia subtypes. The same relation was, then, shown between gene and chromosome rearrangements. It becomes now obvious that genes involved in malignant proliferations may rearrange several different partner genes, as for instance the genes MLL, localised to chromosome band 11q23, and ETV6/TEL to 12p13, The study of these rearrangements is of particular importance in order to improve our knowledge of the functions of rearranged genes as well as their normal counterparts, and to analyse mechanisms favoring the occurrence of chromosomal rearrangements in malignancies.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 50 条
  • [11] Centric and pericentric chromosome rearrangements in hematopoietic malignancies
    Berger, R
    Busson-Le Coniat, M
    LEUKEMIA, 1999, 13 (05) : 671 - 678
  • [12] Chromosomal rearrangements and fusion genes in carcinoma
    Massard, Christophe
    Auger, Nathalie
    Lacroix, Ludovic
    Benard, Jean
    BULLETIN DU CANCER, 2011, 98 (12) : 1395 - 1401
  • [13] CHROMOSOMAL REARRANGEMENTS AND EVOLUTION OF HAPTOGLOBIN GENES
    SMITHIES, O
    CONNELL, GE
    DIXON, GH
    NATURE, 1962, 196 (4851) : 232 - &
  • [14] In-depth mutation scanning of signaling pathway genes involved in the development and targeted treatment of hematopoietic malignancies.
    Lilleberg, SL
    Durocher, J
    Hempel, J
    Wasserburger, C
    Koul, M
    Troy, J
    Nickerson, ML
    BLOOD, 2005, 106 (11) : 179B - 179B
  • [15] Minimal effective dose of the hypomethylating agent Decitabine in hematopoietic malignancies.
    Issa, JP
    Garcia-Manero, G
    Mannari, R
    Thomas, D
    Giles, F
    Cortes, J
    Estey, E
    Kantarjian, H
    BLOOD, 2001, 98 (11) : 594A - 595A
  • [16] Aberrations of the MMAC1/PTEN gene in hematopoietic malignancies.
    Gronbaek, K
    Ralfkiaer, E
    Zeuthen, J
    Guldberg, P
    BLOOD, 1997, 90 (10) : 2195 - 2195
  • [17] Hematopoietic growth factors:: In vitro effect on B cell malignancies.
    Viser, HPJ
    Tewis, M
    Willemze, R
    Kluin-Nelemans, JC
    BLOOD, 1999, 94 (10) : 87A - 87A
  • [18] Chromosomal rearrangements and fusion genes in hematology.
    Mecucci, C
    CYTOGENETICS AND CELL GENETICS, 1997, 77 (1-2): : W85 - W85
  • [19] Dysregulation of apoptosis genes in hematopoietic malignancies
    Shinichi Kitada
    Irene M Pedersen
    Aaron D Schimmer
    John C Reed
    Oncogene, 2002, 21 : 3459 - 3474
  • [20] Dysregulation of apoptosis genes in hematopoietic malignancies
    Kitada, S
    Pedersen, IM
    Schimmer, AD
    Reed, JC
    ONCOGENE, 2002, 21 (21) : 3459 - 3474